IEX

In the past six months (April 2026 to October 2026), IDEX Corp. (IEX) experienced several notable stock events. For Q1 2026, reported April 29, 2026, IDEX reported strong growth with net sales increasing to $886.9 million (up 9% reported, 5% organically) and adjusted diluted EPS reaching $2.00, driven by higher volumes in its Health & Science Technologies segment, particularly in data centers, semiconductors, space, and defense markets, leading to raised full-year guidance. For Q2 2026, reported July 29, 2026, the company announced record sales of $921 million (up 6% reported, 5% organically) and record adjusted diluted EPS of $2.32 (up 12%), with record orders exceeding $1 billion (up 29% reported, 28% organically) due to elevated demand in advantaged markets, especially AI-driven demand in Health & Science Technologies. Conversely, the Fire & Safety/Diversified Products segment saw a 1% decrease in organic sales due to lower European rescue demand and softness in dispensing businesses, yet IDEX again raised its full-year guidance. In September 2026, IDEX declared a regular quarterly cash dividend of $0.73 per share. Over the last year, IDEX Corporation's stock price increased by 41.27%, with a year-to-date total return of 30.66%. Wall Street analysts maintain a 'Moderate Buy' consensus rating, with an average 12-month price target near $260.27, and the stock has outperformed the Industrials sector due to strong earnings and dividend increases.